(1R,2S,3S,5S)-3-(4-Iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylicacid methyl ester

CAS : 135416-43-2

Ref. 3D-FI76761

Informations sur le produit

• Nom: (1R,2S,3S,5S)-3-(4-Iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylicacid methyl ester
• Synonymes: 2b-Carbomethoxy-3b-(4-iodophenyl)tropane, (()-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane, 8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(4-iodophenyl)-8-methyl, methyl ester, (1R,2S,3S,5S)-, 8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(4-iodophenyl)-8-methyl-, methyl ester, [1R-(exo,exo)]-, Iometopane, Methyl (1R,2S,3S,5S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate, Rti 4229-98, Rti 55, β-CIT

Description

(1R,2S,3S,5S)-3-(4-Iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylicacid methyl ester is a molecule that has been shown to be effective in lowering the symptoms of Parkinson's disease. It also prevents the uptake of dopamine and serotonin in the brain by binding to dopamine and serotonin transporters on the cell membrane. This drug has been shown to be safe at doses up to 100 mg/kg/day in rats, but has not been tested in humans. The drug is stable in neutral pH environments and does not degrade upon exposure to light or oxygen.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 385.24 g/mol
• Formule: C₁₆H₂₀INO₂
• Degré de pureté: Min. 95%